Senegenin regulates the mechanism of insomnia through the Keap1/Nrf2/PINK1/Parkin pathway mediated by GAD67
Journal of Sleep Research · 2025
DOI: 10.1111/jsr.14354 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Sleep Research, 2025. Verfasst von Honglin Jia und 7 weiteren Autor:innen. Beteiligte Einrichtung: Xinjiang Medical University Fourth Clinical Medical College, Urumqi, China. Hauptthemen laut MEDLINE: Sleep Initiation and Maintenance Disorders, Glutamate Decarboxylase. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Xinjiang Uygur Autonomous Region, National Natural Science Foundation of China.
Themen: Schlaf
Abstract (Originalsprache)
GAD67 impacts insomnia as a key enzyme catalysing the conversion of glutamate (Glu) to gamma‐aminobutyric acid (GABA). Senegenin enhances neuroprotection and is used widely to treat insomnia and other neurological diseases. This study aimed to investigate how senegenin regulates insomnia through a GAD67‐mediated signalling pathway. We measured GAD67 expression levels in insomnia patients and evaluated the expression levels of GAD67 and Keap1/Nrf2/Parkin/PINK1‐related cytokines following GAD67 lentiviral transfection in PC12 cells and in rat models. We also assessed cellular reactive oxygen species (ROS) and mitochondrial membrane potential levels. Additionally, EEG/EMG was used to analyse the sleep phases of rats and to assess memory and exploration functions. Pathological changes and the expression of GAD67 and sleep‐related proteins in the hippocampus were examined. The results showed that GAD67 expression was increased in insomnia patients, ROS levels were elevated, and the mitochondrial membrane potential was decreased in the GAD67‐KD group. Insomnia rats exhibited changes in sleep rhythm, learning, and exploration dysfunction, pathological changes in the CA1 region of the hippocampus, and differential expression of GAD67 and sleep‐related factors. Inhibitory neurofactor expression levels were decreased in insomnia rats, showing a positive correlation in the GAD67‐KD group and a negative correlation in the GAD67‐OE group. Conversely, excitatory factor expression levels were increased in insomnia rats, showing a positive correlation in the GAD67‐KD group and a negative correlation in the GAD67‐OE group. Senegenin intervention modulated cytokine expression levels. In conclusion, GAD67 negatively regulates insomnia, and senegenin can regulate insomnia by mediating the expression of cytokines in the GAD67‐regulated Keap1/Nrf2/Parkin/PINK1 pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Xinjiang Medical University Fourth Clinical Medical College, Urumqi, China.
- Xinjiang Medical University, Urumqi, China.
- Affiliated Hospital of Traditional Chinese Medicine of Xinjiang Medical University, Urumqi, China.
ORCID-Profile: Xingping Zhang
Förderung
- Natural Science Foundation of Xinjiang Uygur Autonomous Region
- National Natural Science Foundation of China
Zitieren
APA
Jia, H., Chen, X., Liang, Z., Liang, R., Wu, J., Hu, Y., Cui, W., & Zhang, X. (2025). Senegenin regulates the mechanism of insomnia through the Keap1/Nrf2/PINK1/Parkin pathway mediated by GAD67. Journal of Sleep Research. https://doi.org/10.1111/jsr.14354
Vancouver
Jia H, Chen X, Liang Z, Liang R, Wu J, Hu Y, et al. Senegenin regulates the mechanism of insomnia through the Keap1/Nrf2/PINK1/Parkin pathway mediated by GAD67. Journal of Sleep Research. 2025. doi:10.1111/jsr.14354
BibTeX
@article{Jia2025,
author = {Jia, Honglin and Chen, Xu and Liang, Zhengting and Liang, Ruining and Wu, Jinhong and Hu, Yanling and Cui, Wenjun and Zhang, Xingping},
title = {Senegenin regulates the mechanism of insomnia through the Keap1/Nrf2/PINK1/Parkin pathway mediated by GAD67},
journal = {Journal of Sleep Research},
year = {2025},
doi = {10.1111/jsr.14354}
}
EUVIMED